Compare SKIN & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKIN | ARAY |
|---|---|---|
| Founded | 1997 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.9M | 100.5M |
| IPO Year | 2020 | 2006 |
| Metric | SKIN | ARAY |
|---|---|---|
| Price | $1.04 | $0.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $2.00 | ★ $3.50 |
| AVG Volume (30 Days) | 610.2K | ★ 1.1M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 52.63 | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $334,294,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.42 | $4.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.78 | $0.50 |
| 52 Week High | $2.69 | $2.10 |
| Indicator | SKIN | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 37.53 | 38.07 |
| Support Level | N/A | $0.50 |
| Resistance Level | $1.69 | $1.12 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 39.82 | 57.93 |
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.